Index
S&P 500
Market Cap
58.00B
Enterprise Value
63.25B
Income
1.71B
Sales
254.25B
Book/sh
-12.37
Cash/sh
20.97
Employees
63900
IPO
Aug 04, 1983
P/E
34.61
Forward P/E
17.80
PEG
1.55
P/S
0.23
P/B
-
P/C
11.94
P/FCF
12.82
EV/EBITDA
14.93
EV/Sales
0.25
Quick Ratio
0.49
Current Ratio
0.88
Debt/Eq
-
LT Debt/Eq
-
Option/Short
Yes / Yes
EPS (ttm)
7.24
EPS next Y
14.08
EPS next Q
2.94
EPS this Y
11.65%
EPS next Y
11.96%
EPS next 5Y
11.46%
EPS past 3/5Y
79.07% 28.33%
Sales past 3/5Y
7.44% 9.37%
EPS Y/Y TTM
12.28%
Sales Y/Y TTM
14.23%
EPS Q/Q
70.07%
Sales Q/Q
5.84%
Insider Own
0.24%
Insider Trans
-31.22%
Inst Own
92.21%
Inst Trans
-0.46%
ROA
3.10%
ROE
-
ROIC
34.40%
Gross Margin
3.70%
Oper. Margin
1.29%
Profit Margin
0.67%
SMA20
1.70%
SMA50
5.34%
SMA200
12.75%
Trades
Shs Outstand
233.00M
Shs Float
231.00M
52W High
259.21 -3.37%
52W Low
180.45 38.81%
Volatility
2.22% 2.26%
ATR (14)
5.76
RSI (14)
58.45
Beta
0.55
Rel Volume
1.10
Avg Volume
1.78M
Volume
1,945,008
Perf Week
0.36%
Perf Month
8.86%
Perf Quarter
6.32%
Perf Half Y
28.29%
Perf YTD
21.89%
Perf Year
31.94%
Perf 3Y
175.13%
Perf 5Y
423.91%
Perf 10Y
271.08%
Prev Close
251.09
Price
250.48
Change %
-0.24%
Analysts 14 incl. previous ratings
Rating Distribution 14 Buy · 0 Hold · 0 Sell
Date Action Analyst Rating Change Price Target Change Implied Upside Aug 19, 2026 Initiated R RBC Capital Mkts
Outperform $276 +10.2% Apr 28, 2026 Initiated W
Outperform Jan 09, 2026 Upgrade C Citigroup
Neutral → Buy Dec 09, 2025 Initiated B Barclays
Overweight $243 -3.0% Jun 03, 2025 Upgrade W Wells Fargo
Equal Weight → Overweight $179 -28.5% Feb 05, 2025 Upgrade J Jefferies
Hold → Buy $140 → $150 -40.1% Jan 08, 2025 Upgrade T TD Cowen
Hold → Buy $130 → $144 -42.5% Jan 07, 2025 Upgrade E Evercore ISI
In-line → Outperform $140 -44.1% Jan 06, 2025 Upgrade B BofA Securities
Neutral → Buy $132 → $145 -42.1% Dec 13, 2024 Upgrade W Wells Fargo
Underweight → Equal Weight $101 → $127 -49.3% Dec 04, 2024 Resumed M Mizuho
Outperform $139 -44.5% Feb 26, 2024 Initiated L
Outperform $125 -50.1% Feb 09, 2024 Upgrade A
Hold → Buy Jan 03, 2024 Initiated B Barclays
Overweight $117 -53.3% Dec 14, 2023 Initiated W Wells Fargo
Underweight $96 -61.7% Jul 10, 2023 Downgrade E Evercore ISI
Outperform → In-line $100 -60.1% Mar 31, 2023 Initiated C Citigroup
Neutral $77 -69.3% Feb 03, 2023 Upgrade R
Neutral → Outperform $87 → $94 -62.5% Nov 04, 2022 Upgrade B BofA Securities
Underperform → Neutral $64 → $80 -68.1% Aug 22, 2022 Resumed M Morgan Stanley
Overweight $70 → $76 -69.7%
Oct-29-26 01:08PM
Oct-28-26 01:20PM
Oct-21-26 12:29PM
(Investor's Business Daily)
Oct-15-26 03:36PM
Oct-05-26 12:59PM
04:12PM
Loading…
Oct-01-26 04:12PM
08:41AM
06:50AM
06:45AM
Aug-21-26 07:44PM
Aug-19-26 09:38AM
Aug-18-26 07:13AM
Aug-13-26 06:10PM
Aug-11-26 05:03PM
10:13AM
10:07AM
Loading…
10:07AM
(Investor's Business Daily)
09:02AM
(Investor's Business Daily)
08:54AM
08:00AM
07:38AM
07:25AM
(The Wall Street Journal)
07:03AM
06:45AM
06:40AM
05:10AM
04:06AM
Jul-27-26 09:54AM
Jul-21-26 12:15PM
04:46AM
Jul-20-26 04:45PM
09:24AM
Loading…
Jul-09-26 09:24AM
06:45AM
Jul-08-26 02:24PM
May-05-26 04:40PM
Apr-30-26 08:07AM
07:41AM
(The Wall Street Journal)
06:56AM
06:45AM
12:30AM
Apr-28-26 11:45AM
10:19AM
Apr-20-26 12:12PM
Apr-14-26 07:00AM
Apr-07-26 08:20PM
Apr-01-26 07:00AM
Mar-24-26 06:45AM
Mar-23-26 06:45AM
Mar-13-26 04:41PM
(Investor's Business Daily)
09:55AM
Mar-10-26 01:11PM
10:55AM
Mar-09-26 11:53AM
09:40AM
Mar-06-26 07:12PM
11:49AM
11:45AM
11:44AM
Mar-05-26 12:46PM
10:56AM
09:30AM
07:43AM
Mar-04-26 11:35AM
Mar-03-26 10:38PM
07:02PM
09:40AM
09:15AM
Mar-02-26 12:59PM
09:40AM
09:36AM
07:41AM
07:41AM
Feb-28-26 01:28PM
Feb-27-26 12:45PM
12:38PM
12:37PM
07:42AM
Feb-26-26 08:04PM
07:12PM
11:46AM
11:22AM
Feb-25-26 01:55PM
01:55PM
12:51PM
12:49PM
07:50AM
07:26AM
Feb-24-26 12:40PM
12:15PM
08:46AM
07:45AM
07:00AM
Feb-23-26 03:35PM
12:42PM
10:11AM
09:32AM
Feb-20-26 06:11PM
12:22PM
11:48AM
09:11AM
Show Previous News
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Scherer Mary C. Chief Accounting Officer Aug 19 '26 Sale 237.39 2,302 546,473 2,811 Aug 20 04:10 PM Hollar Jason M. Chief Executive Officer Aug 18 '26 Sale 235.74 80,000 18,858,855 235,132 Aug 20 07:33 AM Hollar Jason M. Chief Executive Officer Aug 19 '26 Sale 236.18 44,529 10,516,660 190,603 Aug 20 07:33 AM Mason Stephen M CEO, GMPD Segment Aug 18 '26 Sale 236.40 35,000 8,274,117 18,061 Aug 20 07:30 AM WEITZMAN DEBORAH CEO, PSS Segment Aug 18 '26 Sale 235.45 7,354 1,731,524 77,901 Aug 20 07:30 AM Alt Aaron E Chief Financial Officer Aug 18 '26 Sale 236.34 42,000 9,926,140 20,495 Aug 20 07:29 AM Mayer Jessica L Chief Legal/Compliance Officer Aug 18 '26 Sale 236.19 29,436 6,952,485 33,076 Aug 20 07:29 AM Greene Michelle D. Chief Information Officer Aug 18 '26 Sale 235.72 11,650 2,746,187 10,330 Aug 20 07:28 AM Mary Scherer Officer Aug 19 '26 Proposed Sale 237.39 2,302 546,462 Aug 19 04:27 PM Aaron Alt Officer Aug 18 '26 Proposed Sale 236.34 42,000 9,926,183 Aug 18 04:46 PM Michelle Greene Officer Aug 18 '26 Proposed Sale 235.72 11,650 2,746,148 Aug 18 04:46 PM Deborah Weitzman Officer Aug 18 '26 Proposed Sale 235.45 7,354 1,731,534 Aug 18 04:45 PM Jessica Mayer Officer Aug 18 '26 Proposed Sale 236.19 29,436 6,952,441 Aug 18 04:45 PM Stephen Mason Officer Aug 18 '26 Proposed Sale 236.40 35,000 8,274,153 Aug 18 04:44 PM Jason Hollar Officer Aug 18 '26 Proposed Sale 235.74 124,529 29,356,358 Aug 18 04:44 PM Gregory Kenny Former Director Jun 08 '26 Proposed Sale 203.84 43,542 8,875,761 Jun 08 04:01 PM Greene Michelle D. Chief Information Officer Feb 27 '26 Sale 228.47 2,746 627,387 12,230 Mar 03 04:11 PM Michelle Greene officer Feb 27 '26 Proposed Sale 228.47 2,746 627,387 Feb 27 04:36 PM Alt Aaron E Chief Financial Officer Feb 18 '26 Sale 225.50 2,328 524,964 26,408 Feb 18 04:25 PM Aaron Alt Officer Feb 18 '26 Proposed Sale 225.50 2,328 524,964 Feb 18 04:16 PM Hall Patricia Hemingway Director Feb 06 '26 Sale 229.72 4,000 918,880 28,264 Feb 10 04:13 PM Patricia Hemingway Hall Director Feb 06 '26 Proposed Sale 229.69 4,000 918,760 Feb 06 04:06 PM
Cardinal Health, Inc. is a healthcare services and products company, which engages in the provision of customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, and physician offices. It also provides medical products and pharmaceuticals and cost-effective solutions that enhance supply chain efficiency. The firm operates through the Pharmaceutical and Specialty Solutions Segment and Global Medical Products and Distribution Segment. The Pharmaceutical and Specialty Solutions Segment distributes branded and generic pharmaceutical, specialty pharmaceutical, and over-the-counter healthcare and consumer products in the United States. The Global Medical Products and Distribution Segment manufactures, sources, and distributes Cardinal Health brand medical, surgical, and laboratory products, which are sold in the United States, Canada, Europe, Asia, and other markets. The company was founded by Robert D. Walter in 1979 and is headquartered in Dublin, OH.
CEO & Director Mr. Jason M. Hollar
Chief Financial Officer Mr. Aaron E. Alt J.D.
Chief Legal & Compliance Officer Ms. Jessica L. Mayer
Chief Executive Officer of GMPD segment Mr. Stephen M. Mason
Chief Executive Officer of Pharmaceutical & Specialty Solutions Segment Ms. Deborah L. Weitzman
C